ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tigermed Completes Acquisition of Japanese CRO Micron PRNewswire
July 29, 2025Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Micron,Inc. -
Tigermed Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization prnasia
February 26, 2021China National Medical Products Administration (NMPA) announced on February 25 to grant conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector).
Pharma Sources Insight July 2025
